Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shun Lu

Showing results (501-510 of 661) with videos related to

Pageof 67
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 2, 2015
Symptom and Quality of Life Improvement in LUX-Lung 6: An Open-Label Phase III Study of Afatinib Versus Cisplatin/Gemcitabine in Asian Patients With EGFR Mutation-Positive Advanced Non-small-cell Lung CancerSarayut L Geater, Chong-Rui Xu, Caicun Zhou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2015
TERT Polymorphism rs2736100-C Is Associated with EGFR Mutation-Positive Non-Small Cell Lung CancerRongrong Wei, Lan Cao, Hengying Pu, et al.
Cytotechnology|October 10, 2014
Fluorescent labeling for clonal selection of Marc 145 cells secreting high levels of recombinant protein PBD-1Hai-Jun Huang, Xia Peng, Bing Deng, et al.
Cancer Biology & Therapy|April 17, 2019
The <i>in cis</i> compound <i>EGFR</i> mutations in Chinese advanced non-small cell lung cancer patientsMin Li, Cheng-Zhi Zhou, Jin-Ji Yang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 6, 2015
A multicenter, open-label, randomized phase II controlled study of rh-endostatin (Endostar) in combination with chemotherapy in previously untreated extensive-stage small-cell lung cancerShun Lu, Lu Li, Yi Luo, et al.
International Journal of Clinical Oncology|February 19, 2022
First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in advanced non-small cell lung cancer: a subanalysis of Asian patients in CheckMate 9LAThomas John, Hiroshi Sakai, Satoshi Ikeda, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 23, 2013
Endothelial transdifferentiation in hepatocellular carcinoma: loss of Stabilin-2 expression in peri-tumourous liver correlates with increased survivalCyrill Géraud, Carolin Mogler, Anja Runge, et al.
European Journal of Cancer (Oxford, England : 1990)|January 15, 2026
Preclinical characterization and first-in-human, phase I trial of the novel ALK inhibitor dirozalkib in advanced non-small cell lung cancerXinghao Ai, Renhua Guo, Liang Zhang, et al.
Annals of Translational Medicine|March 12, 2021
Docetaxel maintenance therapy versus best supportive care after first-line chemotherapy with different dose docetaxel plus cisplatin for advanced non-small cell lung cancer (TFINE study, CTONG-0904): an open-label, randomized, phase III trialLi Zhang, Shun Lu, Ying Cheng, et al.
Cells, Tissues, Organs|October 9, 2015
A Novel Organ Culture Model of Mouse Intervertebral Disc TissuesZhengjian Yan, Liangjun Yin, Zhongliang Wang, et al.
Pageof 67

Showing results (501-510 of 661) with videos related to

Sort By:
Pageof 67
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 2, 2015
Symptom and Quality of Life Improvement in LUX-Lung 6: An Open-Label Phase III Study of Afatinib Versus Cisplatin/Gemcitabine in Asian Patients With EGFR Mutation-Positive Advanced Non-small-cell Lung CancerSarayut L Geater, Chong-Rui Xu, Caicun Zhou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2015
TERT Polymorphism rs2736100-C Is Associated with EGFR Mutation-Positive Non-Small Cell Lung CancerRongrong Wei, Lan Cao, Hengying Pu, et al.
Cytotechnology|October 10, 2014
Fluorescent labeling for clonal selection of Marc 145 cells secreting high levels of recombinant protein PBD-1Hai-Jun Huang, Xia Peng, Bing Deng, et al.
Cancer Biology & Therapy|April 17, 2019
The <i>in cis</i> compound <i>EGFR</i> mutations in Chinese advanced non-small cell lung cancer patientsMin Li, Cheng-Zhi Zhou, Jin-Ji Yang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 6, 2015
A multicenter, open-label, randomized phase II controlled study of rh-endostatin (Endostar) in combination with chemotherapy in previously untreated extensive-stage small-cell lung cancerShun Lu, Lu Li, Yi Luo, et al.
International Journal of Clinical Oncology|February 19, 2022
First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in advanced non-small cell lung cancer: a subanalysis of Asian patients in CheckMate 9LAThomas John, Hiroshi Sakai, Satoshi Ikeda, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 23, 2013
Endothelial transdifferentiation in hepatocellular carcinoma: loss of Stabilin-2 expression in peri-tumourous liver correlates with increased survivalCyrill Géraud, Carolin Mogler, Anja Runge, et al.
European Journal of Cancer (Oxford, England : 1990)|January 15, 2026
Preclinical characterization and first-in-human, phase I trial of the novel ALK inhibitor dirozalkib in advanced non-small cell lung cancerXinghao Ai, Renhua Guo, Liang Zhang, et al.
Annals of Translational Medicine|March 12, 2021
Docetaxel maintenance therapy versus best supportive care after first-line chemotherapy with different dose docetaxel plus cisplatin for advanced non-small cell lung cancer (TFINE study, CTONG-0904): an open-label, randomized, phase III trialLi Zhang, Shun Lu, Ying Cheng, et al.
Cells, Tissues, Organs|October 9, 2015
A Novel Organ Culture Model of Mouse Intervertebral Disc TissuesZhengjian Yan, Liangjun Yin, Zhongliang Wang, et al.
Pageof 67